Risk Factors for Hospital-acquired Clostridium difficile Infection Among Pediatric Patients With Cancer

Atsuro Daida1, Hiroki Yoshihara, Ikuko Inai

  • 1*Department of Pediatrics, St. Luke's International Hospital, Chuo-ku, Tokyo †Pediatric Medical Center, Ehime Prefectural Central Hospital, Matsuyama, Ehime ‡Center for Clinical Epidemiology §Research Center, St. Luke's International University, Chuo-ku, Tokyo, Japan.

Insights

Hospital-acquired Clostridium difficile infection (CDI) is a serious risk for children with cancer. Younger age and prolonged neutropenia are key risk factors for developing CDI in this vulnerable population.

Area of Science:

  • Pediatric Oncology
  • Infectious Diseases
  • Epidemiology

Background:

  • Hospital-acquired Clostridium difficile infection (CDI) poses a significant threat, potentially leading to life-threatening colitis in pediatric cancer patients.
  • Identifying risk factors for CDI in this immunocompromised population is crucial for effective prevention and management strategies.

Purpose of the Study:

  • To characterize pediatric cancer patients experiencing primary and recurrent CDI.
  • To evaluate potential risk factors associated with the development of CDI in this cohort.

Main Methods:

  • A case-control study was conducted involving 189 pediatric cancer patients, with 51 diagnosed with CDI and 94 matched controls without CDI.
  • Multivariable logistic regression analysis was employed to assess the association between CDI and various potential risk factors.

Main Results:

  • CDI cases were younger (median age 3.3 years) compared to controls (median age 7.7 years).
  • A longer duration of neutropenia preceding CDI diagnosis was observed in cases (10.0 days) versus controls (6.0 days).
  • Older age (≥7 years) was associated with a reduced risk of CDI (OR=0.11), while prolonged neutropenia increased the risk (OR=1.11).

Conclusions:

  • Younger age and prolonged neutropenia are significant risk factors for hospital-acquired Clostridium difficile infection in pediatric cancer patients.
  • Enhanced awareness of these risk factors can guide targeted prevention efforts and improve outcomes for children undergoing cancer treatment.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.6K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.9K